OSI buying Eyetech for $935 million
SAN FRANCISCO (MarketWatch) - OSI Pharmaceuticals Inc. said Sunday it is buying Eyetech Pharmaceuticals Inc. in a cash-and-stock deal, valued at $935 million, that pays Eyetech shareholders a 43% premium over Friday's closing price of $13.99.
0 Comments:
Post a Comment
<< Home